Protein kinase A regulates GDNF/RET-dependent but not GDNF/Ret-independent ureteric bud outgrowth from the Wolffian duct.
Embryonic kidney development begins with the outgrowth of the ureteric bud (UB) from the Wolffian duct (WD) into the adjacent metanephric mesenchyme (MM). Both a GDNF-dependent and GDNF-independent (Maeshima et al., 2007) pathway have been identified. In vivo and in vitro, the GDNF-dependent pathway is inhibited by BMPs, one of the factors invoked to explain the limitation of UB formation in the unbudded regions of the WD surrounding the UB. However, the exact mechanism remains unknown. Here a previously described in vitro system that models UB budding from the WD was utilized to study this process. Because Protein kinase A (PKA) activation has been shown to prevent migration, morphogenesis and tubulogenesis of epithelial cells (Santos et al., 1993), its activity in budded and non-budded portions of the GDNF-induced WD was analyzed. The level of PKA activity was 15-fold higher in the unbudded portions of the WD compared to budded portions, suggesting that PKA activity plays a key role in controlling the site of UB emergence. Using well-characterized PKA agonists and antagonists, we demonstrated that at various levels of the PKA-signaling hierarchy, PKA regulates UB outgrowth from the WD by suppressing budding events. This process appeared to be PKA-2 isoform specific, and mediated by changes in the duct rather than the surrounding mesenchyme. In addition, it was not due to changes in either the sorting of junctional proteins, cell death, or cell proliferation. Furthermore, the suppressive effect of cAMP on budding did not appear to be mediated by spread to adjacent cells via gap junctions. Conversely, antagonism of PKA activity stimulated UB outgrowth from the WD and resulted in both an increase in the number of buds per unit length of WD as well as a larger surface area per bud. Using microarrays, analysis of gene expression in GDNF-treated WDs in which the PKA pathway had been activated revealed a nearly 14-fold decrease in Ret, a receptor for GDNF. A smaller decrease in GFRα1. a co-receptor for GDNF, was also observed. Using Ret-null WDs, we were able to demonstrate that PKA regulated GDNF-dependent budding but not GDNF-independent pathway for WD budding. We also found that BMP2 was higher in unbudded regions of the GDNF-stimulated WD. Treatment of isolated WDs with BMP2 suppressed budding and resulted in a 3-fold increase in PKA activity. The data suggests that the suppression of budding by BMPs and possibly other factors in non-budded zones of the WD may be regulated in part by increased PKA activity, probably partially through downregulation of Ret/GFRα1 coreceptor expression.
Tee
James B
JB
Department of Pediatrics, University of Calgary and Alberta Children's Hospital, Alberta, Canada.
Choi
Yohan
Y
Shah
Mita M
MM
Dnyanmote
Ankur
A
Sweeney
Derina E
DE
Gallegos
Tom F
TF
Johkura
Kohei
K
Ito
Chiharu
C
Bush
Kevin T
KT
Nigam
Sanjay K
SK
D000818:Animals; D001483:Base Sequence; D055396:Bone Morphogenetic Protein 2 / Q000378:metabolism / Q000494:pharmacology; D049109:Cell Proliferation; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism*; D017931:DNA Primers / Q000235:genetics; D047108:Embryonic Development / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D005260:Female; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000378:metabolism* / Q000494:pharmacology; D007668:Kidney / Q000196:embryology*; D008297:Male; D008648:Mesoderm / Q000196:embryology; D051379:Mice; D018345:Mice, Knockout; D008954:Models, Biological; D011247:Pregnancy; D051096:Proto-Oncogene Proteins c-ret / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction; D014513:Ureter / Q000196:embryology*; D014928:Wolffian Ducts / Q000196:embryology*
C525719:Bmp2 protein, mouse; D055396:Bone Morphogenetic Protein 2; D017931:DNA Primers; D051100:Glial Cell Line-Derived Neurotrophic Factor; D011994:Recombinant Proteins; D051096:Proto-Oncogene Proteins c-ret; C494999:Ret protein, mouse; D017868:Cyclic AMP-Dependent Protein Kinases
J Am Soc Nephrol. 2008 Jan;19(1):117-24
18178801
J Cell Sci. 1990 Aug;96 ( Pt 4):639-49
1704377
Development. 1997 Oct;124(20):4077-87
9374404
Dev Biol. 2004 Feb 15;266(2):285-98
14738877
Am J Physiol. 1993 Jun;264(6 Pt 2):F996-1002
8322902
Nat Genet. 2000 May;25(1):25-9
10802651
J Am Soc Nephrol. 2007 Dec;18(12):3147-55
18003772
J Cell Biochem. 1995 Dec;59(4):453-62
8749715
PLoS Genet. 2010 Jan 15;6(1):e1000809
20084103
J Gen Physiol. 2008 Apr;131(4):293-305
18378798
Neuron. 1998 Jul;21(1):53-62
9697851
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4412-6
7753820
Nat Clin Pract Nephrol. 2008 Jun;4(6):312-25
18446149
Development. 2007 Jul;134(13):2397-405
17522159
Dev Biol. 2008 May 1;317(1):83-94
18358465
Dev Cell. 2004 May;6(5):709-17
15130495
Am J Physiol Renal Physiol. 2007 Aug;293(2):F494-500
17494089
Bioessays. 2008 Feb;30(2):146-55
18200529
Pediatr Nephrol. 1987 Jul;1(3):385-92
3153305
Dev Cell. 2009 Aug;17(2):199-209
19686681
Am J Physiol. 1994 Aug;267(2 Pt 2):F271-80
8067388
Kidney Int. 2003 Dec;64(6):2320-2
14633158
Mol Endocrinol. 2004 Jan;18(1):1-12
14525956
Dev Biol. 2005 Jul 1;283(1):70-84
15890330
Am J Physiol. 1997 Jan;272(1 Pt 2):F139-46
9039060
Nature. 1996 Jul 4;382(6586):73-6
8657307
Biochemistry. 2000 Aug 1;39(30):8803-12
10913291
Development. 2004 Jul;131(14):3401-10
15201225
Differentiation. 2006 Sep;74(7):402-21
16916378
J Anat. 2004 Apr;204(4):241-55
15061751
Development. 1998 Feb;125(4):609-20
9435282
Annu Rev Physiol. 2000;62:595-620
10845104
J Clin Invest. 2000 Apr;105(7):863-73
10749566
Development. 1993 Dec;119(4):1005-17
8306871
Development. 2009 Dec;136(24):4213-24
19934016
Development. 1996 Jun;122(6):1919-29
8674430
Am J Physiol. 1997 Dec;273(6):F961-75
9435686
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20938-43
18087037
Bioessays. 2006 Feb;28(2):117-27
16435290
Am J Physiol Renal Physiol. 2009 Nov;297(5):F1330-41
19726549
Dev Biol. 2006 Jul 15;295(2):473-85
16643884
Tissue Eng Part A. 2010 Aug;16(8):2441-55
20214453
Dev Biol. 1993 Oct;159(2):535-48
8405677
Exp Nephrol. 1998 Jul-Aug;6(4):337-51
9690097
Dev Cell. 2005 Feb;8(2):229-39
15691764
Front Biosci. 1997 Jul 01;2:d331-42
9236186
J Biol Chem. 1999 Sep 10;274(37):26305-14
10473586